Triptonide Modulates MAPK Signaling Pathways and Exerts Anticancer Effects via ER Stress-Mediated Apoptosis Induction

Liyun Zheng1,2, Shiji Fang1,2, Junguo Hui3

  • 1Interventional Diagnosis and Treatment Center, Lishui Hospital of Zhejiang University, Lishui, Zhejiang 323000, People's Republic of China.

Abstract

Insights

Triptonide (TN) shows potential as a chemotherapy agent for osteosarcoma (OS). It induces cancer cell death by triggering reactive oxygen species (ROS)-mediated endoplasmic reticulum (ER) stress and apoptosis through MAPK signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Osteosarcoma (OS) is a primary bone cancer and a significant cause of cancer mortality.
  • Triptonide (TN), derived from Tripterygium wilfordii, exhibits diverse biological activities.

Purpose of the Study:

  • To investigate the anti-cancer effects of Triptonide (TN) on human osteosarcoma (OS) cells.
  • To elucidate the molecular mechanisms underlying TN's cytotoxic action in OS.

Main Methods:

  • In vitro assessment of TN's cytotoxic effects on MG63 and U-2OS osteosarcoma cell lines.
  • Analysis of reactive oxygen species (ROS) generation and endoplasmic reticulum (ER) stress markers (PERK, p-EIF2, GRP78, ATF4, CHOP).
  • Evaluation of mitogen-activated protein kinase (MAPK) pathway modulation, including ERK and p38 phosphorylation.

Main Results:

  • TN demonstrated a dose-dependent cytotoxic effect on OS cells.
  • TN-induced cytotoxicity was mediated by increased ROS production, which was reversed by N-acetylcysteine (NAC).
  • TN treatment upregulated ER stress markers and modulated ERK and p38 MAPK pathways, indicating apoptosis induction.

Conclusions:

  • Triptonide (TN) exhibits chemotherapeutic potential against osteosarcoma.
  • TN induces apoptosis in OS cells via ROS-mediated ER stress, involving the p38 and ERK MAPK signaling pathways.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K